Bisphosphonates and breast cancer – From cautious palliation to saving lives
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsAnnals of Oncology, 2012
- Breast-Cancer Adjuvant Therapy with Zoledronic AcidNew England Journal of Medicine, 2011
- Bisphosphonates: The first 40yearsBone, 2011
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyJournal of Clinical Oncology, 2010
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast CancerNew England Journal of Medicine, 2009
- Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow—a long-term follow-upAnnals of Oncology, 2008
- Treatment of bone metastases from breast cancer and myeloma with pamidronateEuropean Journal of Cancer and Clinical Oncology, 1991
- Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.BMJ, 1988
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Use of Dichloromethylene Diphosphonate in Metastatic Bone DiseaseNew England Journal of Medicine, 1983